ALUMIS INC.
Clinical-stage biopharma developing precision medicines for autoimmune diseases.
ALMS | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 280 EAST GRAND AVENUE, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.alumis.com/
- Sector:
- Manufacturing
Description
Alumis Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines for autoimmune and immune-mediated diseases. The company employs a precision medicine approach, leveraging a proprietary data analytics platform to advance its late-stage portfolio of next-generation targeted therapies. Alumis aims to replace broad immunosuppression with more specific treatments, seeking to optimize patient outcomes and address the limitations of existing therapies for a wide range of immune dysfunctions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ALUMIS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ALUMIS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ALUMIS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
